Cargando…
CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer
Aims. CD73 is a membrane associated 5′-ectonucleotidase that has been proposed as prognostic biomarker in various solid tumors. The aim of this study is to evaluate CD73 expression in a cohort of patients with primary bladder cancer in regard to its association with clinicopathological features and...
Autores principales: | Wettstein, Marian S., Buser, Lorenz, Hermanns, Thomas, Roudnicky, Filip, Eberli, Daniel, Baumeister, Philipp, Sulser, Tullio, Wild, Peter, Poyet, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620269/ https://www.ncbi.nlm.nih.gov/pubmed/26543299 http://dx.doi.org/10.1155/2015/785461 |
Ejemplares similares
-
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2015) -
Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study
por: Bieri, Uwe, et al.
Publicado: (2022) -
Modified Immunoscore Improves Prediction of Survival Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer—A Retrospective Digital Pathology Study
por: Bieri, Uwe, et al.
Publicado: (2022) -
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer
por: POYET, CÉDRIC, et al.
Publicado: (2015) -
Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2014)